RE:Wolf guarding the sheep: a good thing...?The "buyer" Carlyle Group, just ganked, their "friend" Baxter, to the tune of Over two hundred million dollars.
Carlyle Group knew Baxter was desperate for cash and CG exploited that to the MAX.
Your narrative is pure fantasy land big boy.
Don't believe me?
Here's what the Wall Street Journal said in early July,
Carlyle in Advanced Talks to Acquire Baxter’s Vantive
Deal would value the Baxter spinoff at more than $4 billion
"
Private-equity firm Carlyle Group CG -1.06%decrease; red down pointing triangle is in exclusive talks to acquire medical-device maker Baxter’s kidney-care spinoff Vantive for more than $4 billion."